A citation-based method for searching scientific literature

Stacey K Mardekian, Alessandro Bombonati, Juan P Palazzo. Hum Pathol 2016
Times Cited: 30







List of co-cited articles
101 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


MCF10DCIS.com xenograft model of human comedo ductal carcinoma in situ.
F R Miller, S J Santner, L Tait, P J Dawson. J Natl Cancer Inst 2000
216
20

Progression from ductal carcinoma in situ to invasive breast cancer: revisited.
Catherine F Cowell, Britta Weigelt, Rita A Sakr, Charlotte K Y Ng, James Hicks, Tari A King, Jorge S Reis-Filho. Mol Oncol 2013
133
16

Ductal carcinoma in situ - update on risk assessment and management.
Jia-Min B Pang, Kylie L Gorringe, Stephen B Fox. Histopathology 2016
29
17

Molecular evolution of breast cancer.
Peter T Simpson, Jorge S Reis-Filho, Theodora Gale, Sunil R Lakhani. J Pathol 2005
338
13

Regulation of in situ to invasive breast carcinoma transition.
Min Hu, Jun Yao, Danielle K Carroll, Stanislawa Weremowicz, Haiyan Chen, Daniel Carrasco, Andrea Richardson, Shelia Violette, Tatiana Nikolskaya, Yuri Nikolsky,[...]. Cancer Cell 2008
360
13



Surgical Excision Without Radiation for Ductal Carcinoma in Situ of the Breast: 12-Year Results From the ECOG-ACRIN E5194 Study.
Lawrence J Solin, Robert Gray, Lorie L Hughes, William C Wood, Mary Ann Lowen, Sunil S Badve, Frederick L Baehner, James N Ingle, Edith A Perez, Abram Recht,[...]. J Clin Oncol 2015
154
10

Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.
Nina Bijker, Philip Meijnen, Johannes L Peterse, Jan Bogaerts, Irène Van Hoorebeeck, Jean-Pierre Julien, Massimiliano Gennaro, Philippe Rouanet, Antoine Avril, Ian S Fentiman,[...]. J Clin Oncol 2006
435
10

Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.
Irene L Wapnir, James J Dignam, Bernard Fisher, Eleftherios P Mamounas, Stewart J Anderson, Thomas B Julian, Stephanie R Land, Richard G Margolese, Sandra M Swain, Joseph P Costantino,[...]. J Natl Cancer Inst 2011
443
10

Molecular phenotypes of DCIS predict overall and invasive recurrence.
K E Williams, N L P Barnes, A Cramer, R Johnson, K Cheema, J Morris, M Howe, N J Bundred. Ann Oncol 2015
66
10

Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial.
Jack Cuzick, Ivana Sestak, Sarah E Pinder, Ian O Ellis, Sharon Forsyth, Nigel J Bundred, John F Forbes, Hugh Bishop, Ian S Fentiman, William D George. Lancet Oncol 2011
320
10

Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis.
Karla Kerlikowske, Annette M Molinaro, Mona L Gauthier, Hal K Berman, Fred Waldman, James Bennington, Henry Sanchez, Cynthia Jimenez, Kim Stewart, Karen Chew,[...]. J Natl Cancer Inst 2010
231
10

Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes.
Beth A Virnig, Todd M Tuttle, Tatyana Shamliyan, Robert L Kane. J Natl Cancer Inst 2010
370
10


Epithelial-mesenchymal transition increases during the progression of in situ to invasive basal-like breast cancer.
Yoomi Choi, Hee Jin Lee, Min Hye Jang, Jae Moon Gwak, Kyu Sang Lee, Eun Joo Kim, Hyun Jeong Kim, Hee Eun Lee, So Yeon Park. Hum Pathol 2013
64
10

Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA.
Stefano Volinia, Marco Galasso, Maria Elena Sana, Timothy F Wise, Jeff Palatini, Kay Huebner, Carlo M Croce. Proc Natl Acad Sci U S A 2012
271
10

Protocol for the examination of specimens from patients with ductal carcinoma in situ of the breast.
Susan C Lester, Shikha Bose, Yunn-Yi Chen, James L Connolly, Monica E de Baca, Patrick L Fitzgibbons, Daniel F Hayes, Celina Kleer, Frances P O'Malley, David L Page,[...]. Arch Pathol Lab Med 2009
97
10

Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses' Health Study.
Laura C Collins, Rulla M Tamimi, Heather J Baer, James L Connolly, Graham A Colditz, Stuart J Schnitt. Cancer 2005
170
10

The distribution of ductal carcinoma in situ (DCIS) grade in 4232 women and its impact on overdiagnosis in breast cancer screening.
P A van Luijt, E A M Heijnsdijk, J Fracheboud, L I H Overbeek, M J M Broeders, J Wesseling, G J den Heeten, H J de Koning. Breast Cancer Res 2016
39
10

Ductal carcinoma in situ: a proposal for a new classification.
R Holland, J L Peterse, R R Millis, V Eusebi, D Faverly, M J van de Vijver, B Zafrani. Semin Diagn Pathol 1994
436
10



RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation.
Beryl McCormick, Kathryn Winter, Clifford Hudis, Henry Mark Kuerer, Eileen Rakovitch, Barbara L Smith, Nour Sneige, Jennifer Moughan, Amit Shah, Isabelle Germain,[...]. J Clin Oncol 2015
227
10

Breast Cancer-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.
Armando E Giuliano, James L Connolly, Stephen B Edge, Elizabeth A Mittendorf, Hope S Rugo, Lawrence J Solin, Donald L Weaver, David J Winchester, Gabriel N Hortobagyi. CA Cancer J Clin 2017
367
10

Integrated genomic and transcriptomic analysis of ductal carcinoma in situ of the breast.
Anne Vincent-Salomon, Carlo Lucchesi, Nadège Gruel, Virginie Raynal, Gaëlle Pierron, Rémi Goudefroye, Fabien Reyal, François Radvanyi, Rémy Salmon, Jean-Paul Thiery,[...]. Clin Cancer Res 2008
111
10

Molecular portraits of human breast tumours.
C M Perou, T Sørlie, M B Eisen, M van de Rijn, S S Jeffrey, C A Rees, J R Pollack, D T Ross, H Johnsen, L A Akslen,[...]. Nature 2000
10

Cancer statistics, 2018.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2018
10

Cancer statistics: Breast cancer in situ.
Elizabeth M Ward, Carol E DeSantis, Chun Chieh Lin, Joan L Kramer, Ahmedin Jemal, Betsy Kohler, Otis W Brawley, Ted Gansler. CA Cancer J Clin 2015
139
10


Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells.
Shin-ichiro Ohno, Masakatsu Takanashi, Katsuko Sudo, Shinobu Ueda, Akio Ishikawa, Nagahisa Matsuyama, Koji Fujita, Takayuki Mizutani, Tadaaki Ohgi, Takahiro Ochiya,[...]. Mol Ther 2013
905
6


Tumour invasion and metastasis initiated by microRNA-10b in breast cancer.
Li Ma, Julie Teruya-Feldstein, Robert A Weinberg. Nature 2007
6

A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast.
Lawrence J Solin, Robert Gray, Frederick L Baehner, Steven M Butler, Lorie L Hughes, Carl Yoshizawa, Diana B Cherbavaz, Steven Shak, David L Page, George W Sledge,[...]. J Natl Cancer Inst 2013
315
6


HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ.
E Rakovitch, S Nofech-Mozes, W Hanna, S Narod, D Thiruchelvam, R Saskin, J Spayne, C Taylor, L Paszat. Br J Cancer 2012
88
6

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.
Soonmyung Paik, Steven Shak, Gong Tang, Chungyeul Kim, Joffre Baker, Maureen Cronin, Frederick L Baehner, Michael G Walker, Drew Watson, Taesung Park,[...]. N Engl J Med 2004
6

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
E Senkus, S Kyriakides, S Ohno, F Penault-Llorca, P Poortmans, E Rutgers, S Zackrisson, F Cardoso. Ann Oncol 2015
887
6

Her2 and Ki67 Biomarkers Predict Recurrence of Ductal Carcinoma in Situ.
James E Davis, Barbara Nemesure, Saira Mehmood, Vipul Nayi, Stephanie Burke, Sabrina R Brzostek, Meenakshi Singh. Appl Immunohistochem Mol Morphol 2016
22
9

Epidemiology of ductal carcinoma in situ.
Karla Kerlikowske. J Natl Cancer Inst Monogr 2010
122
6

Hormonal receptor status, Ki-67 and HER2 expression: Prognostic value in the recurrence of ductal carcinoma in situ of the breast?
Nikiforita Poulakaki, Georgios-Marios Makris, Marco-Johannes Battista, Daniel Böhm, Kalliopi Petraki, Dimitrios Bafaloukos, Theodoros N Sergentanis, Charalampos Siristatidis, Charalampos Chrelias, Nikolaos Papantoniou. Breast 2016
17
11

A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone.
Eileen Rakovitch, Sharon Nofech-Mozes, Wedad Hanna, Frederick L Baehner, Refik Saskin, Steven M Butler, Alan Tuck, Sandip Sengupta, Leela Elavathil, Prashant A Jani,[...]. Breast Cancer Res Treat 2015
137
6

Tumor characteristics as predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis.
Shi-Yi Wang, Tatyana Shamliyan, Beth A Virnig, Robert Kane. Breast Cancer Res Treat 2011
97
6

Clinicopathologic characteristics and molecular subtypes of microinvasive carcinoma of the breast.
Li Wang, Wei Zhang, Shuhua Lyu, Xia Liu, Tongxian Zhang, Shan Liu, Ying Qin, Xiaoqi Tian, Yun Niu. Tumour Biol 2015
23
8

A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications.
Boudewijn J M Braakhuis, Maarten P Tabor, J Alain Kummer, C René Leemans, Ruud H Brakenhoff. Cancer Res 2003
856
6

Immunohistochemical analysis of cancer stem cell markers in invasive breast carcinoma and associated ductal carcinoma in situ: relationships with markers of tumor hypoxia and microvascularity.
Margaret J Currie, Brooke E Beardsley, Gavin C Harris, Sarah P Gunningham, Gabi U Dachs, Birgit Dijkstra, Helen R Morrin, J Elisabeth Wells, Bridget A Robinson. Hum Pathol 2013
50
6

Next-generation sequencing: a powerful tool for the discovery of molecular markers in breast ductal carcinoma in situ.
Hitchintan Kaur, Shihong Mao, Seema Shah, David H Gorski, Stephen A Krawetz, Bonnie F Sloane, Raymond R Mattingly. Expert Rev Mol Diagn 2013
27
7

Histological and biological evolution of human premalignant breast disease.
D C Allred, S K Mohsin, S A Fuqua. Endocr Relat Cancer 2001
251
6


Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.
Antonio C Wolff, M Elizabeth H Hammond, David G Hicks, Mitch Dowsett, Lisa M McShane, Kimberly H Allison, Donald C Allred, John M S Bartlett, Michael Bilous, Patrick Fitzgibbons,[...]. Arch Pathol Lab Med 2014
674
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.